| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 31.10. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.10. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.09. | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 10.09. | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 96 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen | |
| 10.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.08. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 21.07. | NSE - IMAC Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 19.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.07. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 30.06. | IMAC Holdings, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
| 18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.06. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.01. | Pre-market Movers: IMAC Holdings, Planet Image International, SAB Biotherapeutics, MicroCloud Hologram, Avalon Holdings | 854 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green IMAC Holdings, Inc. (BACK) is up over 91% at $1.59.
Planet... ► Artikel lesen | |
| 27.01. | IMAC Holdings, Inc.: IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies | 222 | GlobeNewswire (Europe) | Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to... ► Artikel lesen | |
| 22.11.24 | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 200 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,472 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement | HOUSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,595 | -0,78 % | Lifeward Ltd. Reports Third Quarter 2025 Financial Results | Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%... ► Artikel lesen | |
| EKSO BIONICS | 4,560 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Third Quarter 2025 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 3,600 | +3,45 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,769 | +2,88 % | Rockwell Medical: Umsatzrückgang im dritten Quartal lässt Aktie einbrechen | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 25,640 | +2,48 % | Viridian Therapeutics auf der Stifel-Konferenz: Strategische Positionierung im TED-Markt | ||
| SINTX TECHNOLOGIES | 3,390 | 0,00 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 4,050 | -18,18 % | Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update | Clinical and research progress continues alongside substantial cost reductions.
Conference Call Today at 4:30 p.m. ET
SAN DIEGO, Nov. 12, 2025 /PRNewswire/... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| NEURONETICS | 1,444 | +1,69 % | Neuronetics: TRICARE West Expands NeuroStar TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression | ||
| HVIVO | 0,063 | 0,00 % | hVIVO develops three new human challenge models for viral testing |